Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1978 Dec;15(6):428–434. doi: 10.1136/jmg.15.6.428

Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia.

M W Spence, J T Clarke, D M D'Entremont, G A Sapp, E R Smith, A L Goldbloom, G Davar
PMCID: PMC1013757  PMID: 218016

Abstract

Eighteen males, 17 of whom were members of a single family, affected with angiokeratoma corporis diffusum were examined in detail to determine the extent of clinical variation of the expression of what was almost certainly the same X-linked mutation in each. The commonest symptom was episodic bouts of severe, painful dysaesthesia in hands and feet. This was a major complaint of 12, a minor complaint of 5, and absent in 1. In over half the subjects, the skin rash that is considered a characteristic sign of the disease was absent or inconspicuous. All exhibited mild clubbing of fingers and toes, and 15 showed variable limitation of active and passive extension of the 5th fingers bilaterally. Only 2 (age 36 and 47) had evidence of significant renal disease. Electrocardiograms showed abnormally short PR intervals in 4, and right ventricular conduction disturbances in 5. Echocardiograms on 9 showed no evidence of myocardial dysfunction. The marked variation of the expression of some features of the disease indicates that the clinical expression of the mutation is likely to be subject to considerable genetic or environmental modification in each individual.

Full text

PDF
428

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartimmo E. E., Jr, Guisan M., Moser K. M. Pulmonary involvement in Fabry's disease: a reappraisal follow-up of a San Diego kindred and review of literature. Am J Med. 1972 Dec;53(6):755–764. doi: 10.1016/0002-9343(72)90194-5. [DOI] [PubMed] [Google Scholar]
  2. Brady R. O., Gal A. E., Bradley R. M., Martensson E., Warshaw A. L., Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med. 1967 May 25;276(21):1163–1167. doi: 10.1056/NEJM196705252762101. [DOI] [PubMed] [Google Scholar]
  3. Clarke J. T., Knaack J., Crawhall J. C., Wolfe L. S. Ceramide trihexosidosis (fabry's disease) without skin lesions. N Engl J Med. 1971 Feb 4;284(5):233–235. doi: 10.1056/NEJM197102042840503. [DOI] [PubMed] [Google Scholar]
  4. Clarke J. T., Stoltz J. M., Mulcahey M. R. Neutral glycosphingolipids of serum lipoproteins in Fabry's disease. Biochim Biophys Acta. 1976 May 27;431(2):317–325. doi: 10.1016/0005-2760(76)90152-1. [DOI] [PubMed] [Google Scholar]
  5. Colombi A., Kostyal A., Bracher R., Gloor F., Mazzi R., Thölen H. Angiokeratoma corporis diffusum--Fabry's disease. Helv Med Acta. 1967 Dec;34(1):67–83. [PubMed] [Google Scholar]
  6. Johnston A. W., Weller S. D., Warland B. J. Angiokeratoma corporis diffusum. Some clinical aspects. Arch Dis Child. 1968 Feb;43(227):73–79. doi: 10.1136/adc.43.227.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kint J. A. Fabry's disease: alpha-galactosidase deficiency. Science. 1970 Feb 27;167(3922):1268–1269. doi: 10.1126/science.167.3922.1268. [DOI] [PubMed] [Google Scholar]
  8. LOWN B., GANONG W. F., LEVINE S. A. The syndrome of short P-R interval, normal QRS complex and paroxysmal rapid heart action. Circulation. 1952 May;5(5):693–706. doi: 10.1161/01.cir.5.5.693. [DOI] [PubMed] [Google Scholar]
  9. Opitz J. M., Stiles F. C., Wise D., Race R. R., Sanger R., Von Gemmingen G. R., Kierland R. R., Cross E. G., De Groot W. P. The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus. Am J Hum Genet. 1965 Jul;17(4):325–342. [PMC free article] [PubMed] [Google Scholar]
  10. Philippart M., Sarlieve L., Manacorda A. Urinary glycolipids in Fabry's disease. Their examination in the detection of atypical variants and the pre-symptomatic state. Pediatrics. 1969 Feb;43(2):201–206. [PubMed] [Google Scholar]
  11. Roudebush C. P., Foerster J. M., Bing O. H. The abbreviated PR interval of Fabry's disease. N Engl J Med. 1973 Aug 16;289(7):357–358. doi: 10.1056/NEJM197308162890709. [DOI] [PubMed] [Google Scholar]
  12. SWEELEY C. C., KLIONSKY B. FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID. J Biol Chem. 1963 Sep;238:3148–3150. [PubMed] [Google Scholar]
  13. Spence M. W., Goldbloom A. L., Burgess J. K., D'entremont D., Ripley B. A., Weldon K. L. Heterozygote detection in angiokeratoma corporis diffusum (Anderson-Fabry disease). Studies on plasma, leucocytes, and hair follicles. J Med Genet. 1977 Apr;14(2):91–99. doi: 10.1136/jmg.14.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Spence M. W., MacKinnon K. E., Burgess J. K., d'Entremont D. M., Belitsky P., Lannon S. G., MacDonald A. S. Failure to correct the metabolic defect by renal allotransplantion in Fabry's disease. Ann Intern Med. 1976 Jan;84(1):13–16. doi: 10.7326/0003-4819-84-1-13. [DOI] [PubMed] [Google Scholar]
  15. Urbain G., Philippart M., Peremans J. Fabry's disease with hypogammaglobulinemia and without angiokeratomas. Arch Intern Med. 1969 Jul;124(1):72–76. [PubMed] [Google Scholar]
  16. WISE D., WALLACE H. J., JELLINEK E. H. Angiokeratoma corporis diffusum. A clinical study of eight affected families. Q J Med. 1962 Apr;31:177–206. [PubMed] [Google Scholar]
  17. Wallace H. J. Anderson-Fabry disease. Br J Dermatol. 1973 Jan;88(1):1–23. [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES